Scott Bingham is the Co-Leader of the U.S. Transactions and Diligence practice. Mr. Bingham specializes in providing clients with acquisition advice on engagements, ranging from $30 billion leveraged buyouts and multibillion-dollar ‘white knight’ defenses of hostile takeover targets to million-dollar private equity placements and strategic ‘add-on’ acquisitions. He has more than 20 years of experience, including industry expertise in healthcare and life sciences.
Mr. Bingham has assisted both private equity and corporate clients throughout the deal continuum, including the identification of potential targets, due diligence, contract structuring and negotiations and transition planning, as well as advising clients on technical deal specifications, including leverage recapitalizations, stock versus asset acquisitions and taxation planning considerations.
Mr. Bingham has taken a lead role in developing FTI Consulting’s Healthcare Integrated Diligence platform, which combines financial and tax due diligence, clinical and compliance diligence and operational assessments. Sectors in which Mr. Bingham has experience include renal care, nuclear pharmacy, behavioral health, specialty hospitals (long-term acute care, rehab), home health, urgent care, pathology laboratories, specialty pharmaceuticals, healthcare technology, imaging and for-profit and not-for-profit hospitals.
Prior to joining FTI Consulting, Mr. Bingham was a Managing Director in the Advisory practice at PricewaterhouseCoopers (“PwC”). Mr. Bingham helped start the Atlanta office of the Transaction Services practice for PwC and was the Practice Leader for the Healthcare Transaction Consulting practice at PwC. Prior to joining PwC, Mr. Bingham was Director of Corporate Development for a healthcare-based private equity portfolio company whose primary investors included Welsh, Carson, Anderson & Stowe and William Blair and Co.